Goldman Sachs
DVAX

Goldman Sachs’s Dynavax Technologies DVAX Stock Holding History

Goldman Sachs’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-114,900
Closed -$1.49M – 6156
2025
Q1 		$1.49M Sell
114,900
-4,300
-4% -$56.9K ﹤0.01% 4384
2024
Q4 		$1.52M Buy
119,200
+23,600
+25% +$285K ﹤0.01% 4521
2024
Q3 		$1.06M Buy
+95,600
New +$1.05M ﹤0.01% 4591
2021
Q3 		– Sell
-29,100
Closed -$287K – 6290
2021
Q2 		$287K Buy
+29,100
New +$265K ﹤0.01% 5546
2020
Q4 		– Sell
-41,600
Closed -$180K – 5526
2020
Q3 		$180K Sell
41,600
-147,400
-78% -$1.05M ﹤0.01% 4955
2020
Q2 		$1.68M Buy
+189,000
New +$955K ﹤0.01% 3582
2017
Q4 		– Sell
-122,700
Closed -$2.64M – 6404
2017
Q3 		$2.64M Buy
+122,700
New +$1.94M ﹤0.01% 3737
2015
Q4 		– Sell
-300,000
Closed -$7.36M – 7185
2015
Q3 		$7.36M Buy
+300,000
New +$8.5M ﹤0.01% 2524

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's DVAX Position: Q1 2026 in Review

Goldman Sachs sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 2,153,979 shares — an estimated $33.1M sold.

Goldman Sachs first reported a position in DVAX in Q2 2013 and held it in 50 quarters. The position peaked at $53.4M in Q2 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Goldman Sachs reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 2,153,979 Dynavax Technologies shares in Q1 2026, an estimated $33.1M.
  • Goldman Sachs first reported a position in Dynavax Technologies in Q2 2013 and held it in 50 quarters.
  • Goldman Sachs's Dynavax Technologies position peaked at $53.4M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.